129 related articles for article (PubMed ID: 17303428)
1. Novel chiral isoxazole derivatives: synthesis and pharmacological characterization at human beta-adrenergic receptor subtypes.
Dallanoce C; Frigerio F; De Amici M; Dorsch S; Klotz KN; De Micheli C
Bioorg Med Chem; 2007 Apr; 15(7):2533-43. PubMed ID: 17303428
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of enantiopure Delta2-isoxazoline derivatives and evaluation of their affinity and efficacy profiles at human beta-adrenergic receptor subtypes.
Dallanoce C; Meroni G; De Amici M; Hoffmann C; Klotz KN; De Micheli C
Bioorg Med Chem; 2006 Jul; 14(13):4393-401. PubMed ID: 16530417
[TBL] [Abstract][Full Text] [Related]
3. Isomeric-activity ratios of trimetoquinol enantiomers on beta-adrenergic receptor subtypes: functional and biochemical studies.
Fraundorfer PF; Lezama EJ; Salazar-Bookaman MM; Fertel RH; Miller DD; Feller DR
Chirality; 1994; 6(2):76-85. PubMed ID: 7911313
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological characterization of high-affinity trimetoquinol analogs on guinea pig and human beta adrenergic receptor subtypes: evidence for partial agonism.
Fraundorfer PF; Fertel RH; Miller DD; Feller DR
J Pharmacol Exp Ther; 1994 Aug; 270(2):665-74. PubMed ID: 7915318
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a new, highly specific, beta 3-adrenergic receptor radioligand, [3H]SB 206606.
Muzzin P; Boss O; Mathis N; Revelli JP; Giacobino JP; Willcocks K; Badman GT; Cantello BC; Hindley RM; Cawthorne MA
Mol Pharmacol; 1994 Aug; 46(2):357-63. PubMed ID: 8078497
[TBL] [Abstract][Full Text] [Related]
7. Novel isoxazole carboxamides as growth hormone secretagogue receptor (GHS-R) antagonists.
Liu B; Liu G; Xin Z; Serby MD; Zhao H; Schaefer VG; Falls HD; Kaszubska W; Collins CA; Sham HL
Bioorg Med Chem Lett; 2004 Oct; 14(20):5223-6. PubMed ID: 15380232
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids.
Conti P; De Amici M; Grazioso G; Roda G; Pinto A; Hansen KB; Nielsen B; Madsen U; Bräuner-Osborne H; Egebjerg J; Vestri V; Pellegrini-Giampietro DE; Sibille P; Acher FC; De Micheli C
J Med Chem; 2005 Oct; 48(20):6315-25. PubMed ID: 16190758
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies of phenoxypropanolamine derivatives for beta 3-adrenergic activity.
Ahmed M; Hanaoka Y; Nagatomo T
Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):112P-113P. PubMed ID: 12491799
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological characterization at glutamate receptors of the four enantiopure isomers of tricholomic acid.
Pinto A; Conti P; De Amici M; Tamborini L; Madsen U; Nielsen B; Christesen T; Bräuner-Osborne H; De Micheli C
J Med Chem; 2008 Apr; 51(7):2311-5. PubMed ID: 18338843
[TBL] [Abstract][Full Text] [Related]
11. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
[TBL] [Abstract][Full Text] [Related]
12. The beta3-adrenoceptor agonist 4-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]-phenyl]-benzenesulfonamide (L755507) and antagonist (S)-N-[4-[2-[[3-[3-(acetamidomethyl)phenoxy]-2-hydroxypropyl]amino]-ethyl]phenyl]benzenesulfonamide (L748337) activate different signaling pathways in Chinese hamster ovary-K1 cells stably expressing the human beta3-adrenoceptor.
Sato M; Hutchinson DS; Evans BA; Summers RJ
Mol Pharmacol; 2008 Nov; 74(5):1417-28. PubMed ID: 18684840
[TBL] [Abstract][Full Text] [Related]
13. Are so many adrenergic receptor subtypes really present in domestic animal tissues? A pharmacological perspective.
Badino P; Odore R; Re G
Vet J; 2005 Sep; 170(2):163-74. PubMed ID: 16129337
[TBL] [Abstract][Full Text] [Related]
14. High-throughput screening with a miniaturized radioligand competition assay identifies new modulators of human α2-adrenoceptors.
Fallarero A; Pohjanoksa K; Wissel G; Parkkisenniemi-Kinnunen UM; Xhaard H; Scheinin M; Vuorela P
Eur J Pharm Sci; 2012 Dec; 47(5):941-51. PubMed ID: 22982401
[TBL] [Abstract][Full Text] [Related]
15. New isoxazole derivatives with a potent and selective beta 2-adrenergic activity.
Chiarino D; Fantucci M; Carenzi A; Della Bella D; Frigeni V; Sala R
Farmaco Sci; 1986 Jun; 41(6):440-53. PubMed ID: 2874994
[TBL] [Abstract][Full Text] [Related]
16. N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice.
Franchetti P; Cappellacci L; Vita P; Petrelli R; Lavecchia A; Kachler S; Klotz KN; Marabese I; Luongo L; Maione S; Grifantini M
J Med Chem; 2009 Apr; 52(8):2393-406. PubMed ID: 19317449
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2).
Langer I; Gaspard N; Robberecht P
Br J Pharmacol; 2006 Aug; 148(8):1051-9. PubMed ID: 16783404
[TBL] [Abstract][Full Text] [Related]
18. Stereospecific synthesis and bio-activity of novel beta(3)-adrenoceptor agonists and inverse agonists.
Perrone MG; Santandrea E; Bleve L; Vitale P; Colabufo NA; Jockers R; Milazzo FM; Sciarroni AF; Scilimati A
Bioorg Med Chem; 2008 Mar; 16(5):2473-88. PubMed ID: 18083578
[TBL] [Abstract][Full Text] [Related]
19. Tethered yohimbine analogs as selective human alpha2C-adrenergic receptor ligands.
Bavadekar SA; Ma G; Mustafa SM; Moore BM; Miller DD; Feller DR
J Pharmacol Exp Ther; 2006 Nov; 319(2):739-48. PubMed ID: 16873606
[TBL] [Abstract][Full Text] [Related]
20. GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog.
Hicks A; McCafferty GP; Riedel E; Aiyar N; Pullen M; Evans C; Luce TD; Coatney RW; Rivera GC; Westfall TD; Hieble JP
J Pharmacol Exp Ther; 2007 Oct; 323(1):202-9. PubMed ID: 17626794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
